These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 33557648)
21. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors. Xu Y; Zhang XJ; Li WB; Wang XR; Wang S; Qiao XP; Chen SW Eur J Med Chem; 2020 Dec; 208():112780. PubMed ID: 32883643 [TBL] [Abstract][Full Text] [Related]
22. Discovery of novel chalcone-dithiocarbamates as ROS-mediated apoptosis inducers by inhibiting catalase. Fu DJ; Li JH; Yang JJ; Li P; Zhang YB; Liu S; Li ZR; Zhang SY Bioorg Chem; 2019 May; 86():375-385. PubMed ID: 30763884 [TBL] [Abstract][Full Text] [Related]
23. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors. Ma CC; Liu ZP Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599 [TBL] [Abstract][Full Text] [Related]
24. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif. Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives. Yu JY; Li XQ; Wei MX Eur J Med Chem; 2019 May; 169():21-28. PubMed ID: 30852384 [TBL] [Abstract][Full Text] [Related]
26. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies. Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities. Ding J; Liu J; Zhang Z; Guo J; Cheng M; Wan Y; Wang R; Fang Y; Guan Z; Jin Y; Xie SS Bioorg Chem; 2020 Aug; 101():104023. PubMed ID: 32650178 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and evaluation of novel pyridone derivatives as potent BRD4 inhibitors for the potential treatment of prostate cancer. Jiang W; Wang X; Shu C; Hou Q; Yang K; Wu X Bioorg Chem; 2022 Feb; 119():105575. PubMed ID: 34995979 [TBL] [Abstract][Full Text] [Related]
29. Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway. Lin L; Lu W; Dai T; Chen H; Wang T; Yang L; Yang X; Liu Y; Sun D Bioorg Chem; 2021 Jan; 106():104496. PubMed ID: 33288320 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of novel carbamodithioates as anti-proliferative agents against human cancer cells. Liu X; Wang Z; Xie R; Tang P; Yuan Q Eur J Med Chem; 2018 Sep; 157():1526-1540. PubMed ID: 30282324 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors. Wang NY; Xu Y; Xiao KJ; Zuo WQ; Zhu YX; Hu R; Wang WL; Shi YJ; Yu LT; Liu ZH Eur J Med Chem; 2020 Apr; 191():112152. PubMed ID: 32088495 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of indoline-maleimide conjugates as potential antitumor agents for the treatment of colorectal cancer. Tang J; Zhang Y; Zhou L; Song X; Wei Y; Qi J; Wu J; Song Z; Zhan L Bioorg Med Chem; 2024 Jun; 108():117786. PubMed ID: 38843656 [TBL] [Abstract][Full Text] [Related]
33. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies. Kamath PR; Sunil D; Ajees AA; Pai KS; Das S Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742 [TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity, Pro-apoptotic Activity and in silico Studies of Dithiocarbamates and their Structure Based Design and SAR Studies. Hamdani SS; Khan BA; Hameed S; Rashid F; Zaib S; Ahmad K; Mughal EU; Iqbal J Med Chem; 2019; 15(8):892-902. PubMed ID: 30747078 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents. Ding PP; Gao M; Mao BB; Cao SL; Liu CH; Yang CR; Li ZF; Liao J; Zhao H; Li Z; Li J; Wang H; Xu X Eur J Med Chem; 2016 Jan; 108():364-373. PubMed ID: 26703795 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates. Wang XJ; Xu HW; Guo LL; Zheng JX; Xu B; Guo X; Zheng CX; Liu HM Bioorg Med Chem Lett; 2011 May; 21(10):3074-7. PubMed ID: 21486694 [TBL] [Abstract][Full Text] [Related]
37. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines. Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254 [TBL] [Abstract][Full Text] [Related]
38. Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. Sabt A; Abdelhafez OM; El-Haggar RS; Madkour HMF; Eldehna WM; El-Khrisy EEAM; Abdel-Rahman MA; Rashed LA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1095-1107. PubMed ID: 29944015 [TBL] [Abstract][Full Text] [Related]
39. Identification of (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-dithiocarbamate-nitrostyrene hybrid as potent antiproliferative and apoptotic inducing agent against cervical cancer cell lines. Laskar S; Sánchez-Sánchez L; Flores SM; López-Muñoz H; Escobar-Sánchez ML; López-Ortiz M; Hernández-Rodríguez M; Regla I Eur J Med Chem; 2018 Feb; 146():621-635. PubMed ID: 29407986 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents. Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]